Loreto Carmona

43.9k total citations · 5 hit papers
370 papers, 14.0k citations indexed

About

Loreto Carmona is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Loreto Carmona has authored 370 papers receiving a total of 14.0k indexed citations (citations by other indexed papers that have themselves been cited), including 215 papers in Rheumatology, 79 papers in Hematology and 57 papers in Immunology. Recurrent topics in Loreto Carmona's work include Rheumatoid Arthritis Research and Therapies (165 papers), Autoimmune and Inflammatory Disorders Research (76 papers) and Spondyloarthritis Studies and Treatments (65 papers). Loreto Carmona is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (165 papers), Autoimmune and Inflammatory Disorders Research (76 papers) and Spondyloarthritis Studies and Treatments (65 papers). Loreto Carmona collaborates with scholars based in Spain, United Kingdom and United States. Loreto Carmona's co-authors include Juan J. Gómez‐Reino, M.Á. Descalzo, Emilio Martín Mola, Estíbaliz Loza, Vicente Rodríguez Valverde, Eva Salgado, Juan Ángel Jover, José Ramón Maneiro, Lydia Abásolo and Isidoro González‐Álvaro and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Loreto Carmona

343 papers receiving 13.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study

2014 839 citations Loreto Carmona, Anthony D. Woolf et al. Annals of the Rheumatic Diseases profile →
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active‐surveillance report

2003 784 citations Loreto Carmona et al. profile →
The burden of musculoskeletal diseases in the general population of Spain: results from a national survey

2001 500 citations Loreto Carmona et al. Annals of the Rheumatic Diseases profile →
2018 update of the EULAR recommendations for the management of hand osteoarthritis

2018 308 citations Féline P B Kroon, Krysia Dziedzic et al. Annals of the Rheumatic Diseases profile →
2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis

2021 171 citations Elena Nikiphorou, Andréa Marques et al. Annals of the Rheumatic Diseases profile →

Peers

Countries citing papers authored by Loreto Carmona

Since Specialization

Citations

This map shows the geographic impact of Loreto Carmona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loreto Carmona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loreto Carmona more than expected).

Fields of papers citing papers by Loreto Carmona

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loreto Carmona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loreto Carmona. The network helps show where Loreto Carmona may publish in the future.

Co-authorship network of co-authors of Loreto Carmona

This figure shows the co-authorship network connecting the top 25 collaborators of Loreto Carmona. A scholar is included among the top collaborators of Loreto Carmona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loreto Carmona. Loreto Carmona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Economic Impact of Allergic Diseases and Asthma—The HEAD Pan‐European Registry 2025 ·Allergy ·Ioana Agache, Marı́a José Torres, Ibon Eguíluz‐Gracia, (unknown), (unknown), Maria Beatrice Bilò, Federica Rivolta, (unknown), Roxana Silvia Bumbăcea, (unknown), Darío Antolín‐Amérigo, (unknown), (unknown), (unknown), Paulo Nogueira, Loreto Carmona, (unknown)	1
2	Efficacy and safety of therapies for Still's disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still's disease 2024 ·Annals of the Rheumatic Diseases ·Sara Bindoli, (unknown), Stéphane Mitrovic, Bruno Fautrel, Loreto Carmona, Fabrizio De Benedetti	12
3	Empowering rheumatology through digital health technologies: contributions and barriers 2024 ·SHILAP Revista de lepidopterología ·Diego Benavent, Loreto Carmona, (unknown), María Montoro, Susan Elizabeth Ramírez, Teresa Otón, Estíbaliz Loza, (unknown)	2
4	The patient journey of fibromyalgia in Latin America 2024 ·Reumatología Clínica (English Edition) ·Teresa Otón, Osvaldo Daniel Messina, Daniel G. Fernández‐Ávila, (unknown), (unknown), (unknown), (unknown), (unknown), Loreto Carmona	3
5	Sesgos de género en la reumatología española: Percepciones y realidad 2023 ·Reumatología Clínica ·(unknown), Isabel Castrejón, Blanca Hernández‐Cruz, (unknown), Rosario García‐Vicuña, Montserrat Romera Baurés, Patrícia Carreira, Esperanza Naredo, Dèlia Reina, María Galindo-Izquierdo, (unknown), (unknown), Loreto Carmona	0
6	El viaje del paciente con fibromialgia en Latinoamérica 2023 ·Reumatología Clínica ·Teresa Otón, Osvaldo Daniel Messina, Daniel G. Fernández‐Ávila, (unknown), (unknown), (unknown), (unknown), (unknown), Loreto Carmona	0
7	Psychometric properties of outcome measurement instruments for ANCA-associated vasculitis: a systematic literature review 2022 ·Lara D. Veeken ·Alvise Berti, Gonçalo Boleto, Peter A. Merkel, Gunnar Tómasson, Sara Monti, Kaitlin A. Quinn, Leslie C. Hassett, Loreto Carmona, Sofía Ramiro	9
8	Measurement Properties of Outcome Instruments for Large-Vessel Vasculitis: A Systematic Literature Review 2022 ·The Journal of Rheumatology ·Gonçalo Boleto, Alvise Berti, Peter A. Merkel, Sibel Zehra Aydın, Haner Di̇reskeneli̇, Christian Dejaco, Leslie C. Hassett, Loreto Carmona, Sofía Ramiro	4
9	Implementation of recommendations in rheumatic and musculoskeletal diseases: considerations for development and uptake 2022 ·Annals of the Rheumatic Diseases ·Estíbaliz Loza, Loreto Carmona, Anthony D. Woolf, Bruno Fautrel, Delphine S. Courvoisier, Suzanne Verstappen, Sella Aarrestad Provan, Annelies Boonen, T. P. M. Vliet Vlieland, Francesca Marchiori, (unknown), Kristien Van der Elst, Mwidimi Ndosi, Krysia Dziedzic, José Miguel Carrasco	7
10	EULAR COVID-19 registry: lessons learnt and future considerations 2021 ·Annals of the Rheumatic Diseases ·Saskia Lawson‐Tovey, Anja Strangfeld, Kimme L Hyrich, Loreto Carmona, (unknown), Laure Gossec, Elsa F Mateus, Pedro Machado	4
11	EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2 2020 ·Annals of the Rheumatic Diseases ·Robert Landewé, Pedro Machado, Féline P B Kroon, Hans Bijlsma, Gerd R Burmester, Loreto Carmona, Bernard Combe, Massimo Galli, Laure Gossec, Annamaria Iagnocco, John D. Isaacs, Xavier Mariette, Iain B. McInnes, Ulf Müeller-Ladner, Peter Openshaw, Josef S Smolen, Tanja Stamm, Dieter Wiek, Hendrik Schulze‐Koops	153
12	Prevention, screening, assessing and managing of non-adherent behaviour in people with rheumatic and musculoskeletal diseases: systematic reviews informing the 2020 EULAR points to consider 2020 ·RMD Open ·Valentin Ritschl, Tanja Stamm, Daniel Aletaha, J. W. J. Bijlsma, Peter Böhm, Răzvan Drăgoi, Emma Dures, Fernando Estévez‐López, Laure Gossec, Annamaria Iagnocco, (unknown), Michal Nudel, Andréa Marques, (unknown), Conni Skrubbeltrang, Bart J. F. van den Bemt, Kirsten K. Viktil, Marieke Voshaar, Loreto Carmona, Annette de Thurah	23
13	2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practice 2020 ·Annals of the Rheumatic Diseases ·Valentin Ritschl, Tanja Stamm, Daniel Aletaha, J. W. J. Bijlsma, Peter Böhm, Răzvan Drăgoi, Emma Dures, Fernando Estévez‐López, Laure Gossec, Annamaria Iagnocco, Andréa Marques, (unknown), Michal Nudel, Bart J. F. van den Bemt, Kirsten K. Viktil, Marieke Voshaar, Annette de Thurah, Loreto Carmona	34
14	Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study 2020 ·Annals of the Rheumatic Diseases ·José L. Pablos, María Galindo-Izquierdo, Loreto Carmona, A. Lledó, Miriam Retuerto, Ricardo Blanco, Miguel Á. González‐Gay, David Martínez‐López, Isabel Castrejón, José María Álvaro‐Gracia, David Fernandez-Fernández, Antonio Mera, Sara Manrique‐Arija, Natalia Mena‐Vázquez, Antonio Fernández‐Nebro	137
15	EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases 2019 ·RMD Open ·Aurélie Najm, Elena Nikiphorou, Marie Kostine, Christophe Richez, John D Pauling, Axel Finckh, Valentin Ritschl, Yeliz Prior, Petra Balážová, Simon Stones, Zoltán Szekanecz, Annamaria Iagnocco, Sofía Ramiro, Francisca Sivera, Maxime Dougados, Loreto Carmona, Gerd R Burmester, Dieter Wiek, Laure Gossec, Francis Bérenbaum	67
16	Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study. 2017 ·PubMed ·Jaime Calvo‐Alén, I. Monteagudo, Georgina Salvador, Tomás R. Vázquez-Rodríguez, (unknown), Paloma Vela, (unknown), Sagrario Bustabad, (unknown), (unknown), J. Rosas, Enrique Raya, Loreto Carmona, Luis Cea‐Calvo, (unknown), (unknown), Carlos Marras	28
17	OP0340 Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal observational studies 2017 ·Annals of the Rheumatic Diseases ·(unknown), (unknown), Marius Henriksen, Henrik Gudbergsen, Henning Bliddal, Arne Astrup, Filip K. Knop, Loreto Carmona, W Taylor, Jasvinder A. Singh, Fernando Pérez-Ruiz, (unknown), Robin Christensen	1
18	Adherence to biologic therapies and associated factors in rheumatoid arthritis, spondyloarthritis and psoriatic arthritis: a systematic literature review. 2015 ·PubMed ·(unknown), Leticia León, Estíbaliz Loza, (unknown), María Jesús García de Yébenes, Loreto Carmona	42
19	Early mortality in Australian, Canadian and Spanish scleroderma patients: rationale for establishing a multi-national inception cohort of patients with systemic sclerosis 2014 ·Arthritis & Rheumatology ·Yanjie Hao, Marie Hudson, Patrícia Carreira, Whitney W. Stevens, Candice Rabusa, Solène Tatibouet, Loreto Carmona, Beatriz Joven, (unknown), Maayan Baron, Mandana Nikpour	5
20	Proyecto EPISER 2000: prevalencia de enfermedades reumáticas en la población española.Metodología, resultados del reclutamiento y características de la población 2001 ·Loreto Carmona, Rafael Gabriel, Javier Ballina, A Laffón	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact